Frontiers in Clinical Drug Research -CNS and Neurological Disorders
View Sample
To Avail the Discount Please Click Below.
DEAL OF THE DAY:   US $55.3US $7930%

Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research -CNS and Neurological Disorders

Volume 3

eBook: US $79 Special Offer (PDF + Printed Copy): US $158
Printed Copy: US $119
Library License: US $316
ISSN: 2451-8883 (Print)
ISSN: 2214-7527 (Online)
ISBN: 978-1-60805-927-0 (Print)
ISBN: 978-1-60805-926-3 (Online)
Year of Publication: 2015
DOI: 10.2174/97816080592631140301

Introduction

Frontiers in Clinical Drug Research - CNS and Neurological Disorders is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.

The third volume of this series features six chapters that cover a variety of topics including:

-the role of Potassium transport channels in neuroprotection against tetrahydroprotoberberines

-cannabinoids in cell therapy for CNS disorders

-AMPA Receptor Antagonists

-therapeutic intervention in polyglutamine ataxias

-nutritional therapies in neurology practice

Preface

- Pp. i-ii (2)
Atta-ur-Rahman
Download Free

List of Contributors

- Pp. iii-iv (2)
Atta-ur-Rahman
Download Free

ATP-Sensitive K<sup>+</sup> Channel in Nigra Dopamine Neurons is a Novel Target for Tetrahydroprotoberberines` Neuroprotection

- Pp. 3-18 (16)
Kechun Yang, Devin H. Taylor and Jie Wu

PDF Price: $30

View Abstract Purchase Chapter

Potential Roles of Cannabinoids in Cell Therapy for CNS Neurodegenerative Disorders

- Pp. 19-40 (22)
Massimo Nabissi, Maria Beatrice Morelli, Consuelo Amantini, Sonia Liberati, Valerio Napolioni, Matteo Santoni, Valerio Farfariello, Claudio Cardinali and Giorgio Santoni

PDF Price: $30

View Abstract Purchase Chapter

AMPA Receptor Antagonists for the Treatment of CNS Disorders: Antiepileptics and Beyond

- Pp. 41-76 (36)
Takahisa Hanada, Haichen Yang, Katsutoshi Ido and Antonio Laurenza
View Abstract Download Free

Towards A Therapeutic Intervention in Polyglutamine Ataxias: From Models to Clinical Trials

- Pp. 77-130 (54)
Nadiya Kazachkova and Manuela Lima

PDF Price: $30

View Abstract Purchase Chapter

Dietary Therapy in Pediatric Neurology Practice

- Pp. 131-157 (27)
Sheffali Gulati and Biswaroop Chakrabarty

PDF Price: $30

View Abstract Purchase Chapter

Nutritional and Genotoxic Stress Contributes to Diabetes and Neurodegenerative Diseases such as Parkinson's and Alzheimer's Diseases

- Pp. 158-192 (35)
Ian James Martins
View Abstract Download Free

Subject Index

- Pp. 193-198 (6)
Atta-ur-Rahman
Download Free

RELATED BOOKS

.Frontiers in Clinical Drug Research-Dementia.
.Alzheimer
.Advances in Alzheimer Research.
.Cellular and Molecular Biology of Autism Spectrum Disorders.
.Alzheimer
.Advances in Alzheimer Research.
.Cellular and Molecular Biology of Autism Spectrum Disorders.
.Cellular Mechanisms in Alzheimer’s Disease.